Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Geriatric MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Heart disease and stroke statistics–2009 update.American Heart Association, Dallas (TX)2009
- US population projections.(Available at:) (Accessed April 8, 2009)
- Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age.Circulation. 2006; 113: 791-798
- The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.JAMA. 2003; 289: 2560-2572
- Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (ATP III).JAMA. 2001; 285: 2486-2497
- Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004.J Am Geriatr Soc. 2007; 55: 1056-1065
- Hypertension awareness, treatment, and control – continued disparities in adults: United States, 2005–2006.(NCHS data brief no) National Center for Health Statistics, Hyattsville (MD)2008
- Isolated systolic hypertension in the elderly.N Engl J Med. 2007; 357: 789-796
- Clinical advisory statement. Importance of systolic blood pressure in older Americans.Hypertension. 2000; 35: 1021-1024
- Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.JAMA. 1991; 265: 3255-3264
- Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the Systolic Hypertension in the Elderly Program (SHEP).Stroke. 2008; 39: 1084-1089
- Blood pressure and survival in the oldest old.J Am Geriatr Soc. 2007; 55: 383-388
- Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials (INDIANA).Lancet. 1999; 353: 793-796
- Treatment of hypertension in patients 80 years of age or older (HYVET).N Engl J Med. 2008; 358: 1887-1898
- Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.JAMA. 2002; 288: 2981-2997
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.Lancet. 2002; 359: 995-1003
- Benazepril plus amlodipine or hydrocholorthiazide for hypertension in high-risk patients.N Engl J Med. 2008; 359: 2417-2428
- Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomized trials.BMJ. 2008; 336: 1121-1123
- High serum total cholesterol – an indicator of monitoring cholesterol lowering efforts; U.S. adults, 2005–2006.(NCHS data brief no 2) National Center for Health Statistics, Hyattsville (MD)2007
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group (WOSCOPS).N Engl J Med. 1995; 333: 1301-1307
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.Lancet. 2003; 361: 1149-1158
- Total cholesterol and risk of mortality in the oldest old.Lancet. 1997; 350: 1119-1123
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).Lancet. 1994; 344: 1383-1389
- Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S).Circulation. 1997; 96: 4211-4218
- PROSPER Study Group. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized trial.Lancet. 2002; 360: 1623-1630
- JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.N Engl J Med. 2008; 359: 2195-2207
- Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the US.J Am Coll Cardiol. 2009; 53: 931-935
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial.Lancet. 2002; 360: 7-22
- Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS.Eur Heart J. 2006; 27: 2310-2316
- Collaborative overview of randomised trials of antiplatelet therapy–I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.BMJ. 1994; 308: 81-106
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. CAPRIE Steering Committee.Lancet. 1996; 348: 1329-1339
- Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study.Circulation. 2003; 108: 1682-1687
- Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med. 2001; 345: 494-502
- Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.N Engl J Med. 2006; 354: 1706-1717
- Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators.N Engl J Med. 2000; 342: 145-153
- Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure. The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF).JAMA. 2000; 283: 1295-1302
- Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.Circulation. 2002; 106: 2194-2199
- Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. The CAPRICORN Investigators.Lancet. 2001; 357: 1385-1390
- The influence of cigarette smoking on prognosis after first myocardial infarction.J Chronic Dis. 1978; 31: 415-432
- Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease: results from the CASS registry.N Engl J Med. 1988; 319: 1365-1369
- Secondary prevention of coronary heart disease in the elderly (with emphasis on patients ≥ 75 years of age).Circulation. 2002; 105: 1735-1743
U.S. Department of Health and Human Services. Health People 2010: Understanding and Improving Health. 2nd edition. Washington, DC: US Government Printing Office. November 2000.
Article info
Identification
Copyright
© 2009 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
